萬科企業(02202.HK):鉅盛華及其一致行動人持有公司A股累計變動比例為5%
格隆匯11月22日丨萬科企業(02202.HK)公告,公司於2019年11月22日收到深圳市鉅盛華股份有限公司、前海人壽保險股份有限公司的《萬科企業股份有限公司簡式權益變動報告書》。
2018年9月19日至2019年11月22日,因鉅盛華作為委託人的資產管理計劃寶祿1號通過大宗交易方式減持、信息披露義務人通過深圳證券交易所證券交易系統集中競價交易方式減持以及萬科總股本變動導致信息披露義務人持股比例被動稀釋等原因,鉅盛華及其一致行動人持有的萬科A股股份累計變動比例為5.00%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.